Perioperative Cognitive Protection - Cognitive Exercise and Cognitive Reserve (The Neurobics Trial)
Launched by OHIO STATE UNIVERSITY · Aug 29, 2014
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
Potential study participants will be identified one of two ways, either by the treating physician in clinic when the decision is made to pursue surgery or by researchers monitoring the OR schedule. When a potential participant is identified by the treating physician in clinic, they will ask the patient if study personnel may call them to discuss the study. If the patient agrees to be contacted, the surgeon will alert study personnel who will call the patient to explain the study and arrange the initial study (screening) visit. Study personnel will monitor the OR schedule and call any potent...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. 60 years of age or older
- • 2. Capable and willing to consent
- • 3. Non-cardiac/non-neurological surgery with expected hospital stay of at least 72 H
- • 4. American Society of Anesthesiologists (ASA) physical status I-IV
- • 5. English speaking
- • 6. Willingness to use a provided tablet device
- • 7. Willingness to commit at least 1 hour per day to experimental intervention (cognitive activity/exercise) to complete a minimum of 10 hours within at least 8 days prior to surgery.
- • Exclusion criteria
- • 1. Severe visual or auditory deficits
- • 2. Illiterate
- • 3. Surgery within the previous 6 months requiring general anesthesia
- • 4. Score \< 26 on initial Mini Mental Status Exam (MMSE - modified version) (24 for patients with less than high school education)
- • 5. Positive pre-surgery Confusion Assessment Method test (CAM)
- • 6. Active depression as indicated by Geriatric Depression Scale screening test (score ≥ 10)
- • 7. History of Axis I or II psychiatric disorders including bipolar disorder, schizophrenia, dementia, alcohol or drug abuse
- • 8. ASA physical status V, VI
- • 9. Planned postoperative intubation
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Michelle L Humeidan, MD,PhD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials